|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.5 USD | +3.50% |
|
+5.75% | -10.61% |
| Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
| Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
Francis deSouza is chief executive of Illumina Inc. "Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy Firm Grail -- Update" at 7:53 a.m. ET incorrectly said Mr. deSouza was CEO of Grail. (Sept. 21, 2020)
| 1st Jan change | Capi. | |
|---|---|---|
| -10.61% | 19.15B | |
| +8.35% | 209B | |
| +9.41% | 175B | |
| +11.75% | 131B | |
| +19.34% | 99.98B | |
| -0.84% | 61.12B | |
| +15.08% | 52.34B | |
| -2.10% | 46.5B | |
| +0.10% | 39.24B | |
| +11.50% | 38.47B |
ILLUMINA, INC. 
